Bibliotecas PUC-SP - Busca Integrada

Molecular characterization of AML‐MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC‐defining criteria, TP53 allelic state, or TP53 variant allele freque...

per Davidson Zhao, Entsar Eladl, Mojgan Zarif, José‐Mario Capo‐Chichi, Andre Schuh, Eshetu Atenafu, Mark Minden, Hong Chang
Publicat a Cancer Medicine (2023-03-01)

TP53 Mutations in AML Patients Are Associated with Dismal Clinical Outcome Irrespective of Frontline Induction Regimen and Allogeneic Hematopoietic Cell Transplantation

per Davidson Zhao, Mojgan Zarif, Qianghua Zhou, José-Mario Capo-Chichi, Andre Schuh, Mark D. Minden, Eshetu G. Atenafu, Rajat Kumar, Hong Chang
Publicat a Cancers (2023-06-01)

Impaired T cell responsiveness to interleukin-6 in hematological patients with invasive aspergillosis.

per Jose F Camargo, Alyajahan Bhimji, Deepali Kumar, Rupert Kaul, Rhea Pavan, Andre Schuh, Matthew Seftel, Jeffrey H Lipton, Vikas Gupta, Atul Humar, Shahid Husain
Publicat a PLoS ONE (2015-01-01)

P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE

per Maria Agustina Perusini, Vikas Gupta, Aniket Bankar, Jad Sibai, Mark Minden, Dawn Maze, Marta Davidson, Guillaume Richard-Carpentier, Steven M Chan, Andre Schuh, Karen Yee, Eshetu Atenafu, Hassan Sibai
Publicat a HemaSphere (2023-08-01)

P490: UPDATED SURVIVAL, BLOOD COUNT RECOVERY AND SAFETY RESULTS FROM THE AGILE STUDY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACE...

per Hartmut Döhner, Pau Montesinos, Susana Vives Polo, Ewa Zarzycka, Jianxiang Wang, Marta Riva, Michael Heuser, Rodrigo Calado, Andre Schuh, Su-Peng Yeh, Jianan Hui, Diego Gianolio, Prapti A Patel, Christian Recher, Stephane de Botton
Publicat a HemaSphere (2023-08-01)

P411: LONGITUDINAL CHARACTERIZATION OF MOLECULAR VARIANTS AT REMISSION AND RELAPSE: SUBANALYSIS OF THE QUAZAR AML-001 TRIAL

per Daniel Lopes De Menezes, Andrew Wei, Hartmut Döhner, Gail Roboz, Maria Teresa Voso, Andre Schuh, Wendy L. See, Manuel Ugidos, Arnaud Amzallag, Alberto Risueño, Charalampos Kyriakopoulos, Rajasekhar Nvs Suragani, Barry Skikne, CL Beach, Thomas Prebet, Anita Gandhi
Publicat a HemaSphere (2023-08-01)

Myeloproliferative Neoplasm Driven by <i>ETV6-ABL1</i> in an Adolescent with Recent History of Burkitt Leukemia

per Samuele Renzi, Fatimah Algawahmed, Scott Davidson, Karin P. S. Langenberg, Fabio Fuligni, Salah Ali, Nathaniel Anderson, Ledia Brunga, Jack Bartram, Mohamed Abdelhaleem, Ahmed Naqvi, Kassa Beimnet, Andre Schuh, Anne Tierens, David Malkin, Adam Shlien, Mary Shago, Anita Villani
Publicat a Current Oncology (2023-06-01)

P459: DISEASE MONITORING OF NPM1-MUTANT (MUT) ACUTE MYELOID LEUKEMIA (AML) USING MEASURABLE RESIDUAL DISEASE (MRD) ASSESSMENTS DURING ORAL AZACITIDINE (ORAL-AZA) TREATMENT (TX): A...

per Daniel Lopes De Menezes, Gail Roboz, Hartmut Döhner, Andrew Wei, Maria Teresa Voso, Andre Schuh, Wendy L. See, Manuel Ugidos, Arnaud Amzallag, Alberto Risueño, Kevin H. Eng, Rajasekhar Nvs Suragani, Barry Skikne, CL Beach, Thomas Prebet, Anita Gandhi
Publicat a HemaSphere (2023-08-01)

Clinical Utility of Next-generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single-Center Experience

per Waleed Alduaij, Caroline J. McNamara, Andre Schuh, Andrea Arruda, Mahadeo Sukhai, Nisha Kanwar, Mariam Thomas, Jay Spiegel, James A. Kennedy, Tracy Stockley, Hubert Tsui, Rebecca Devlin, Hassan Sibai, Dawn Maze, Aaron Schimmer, Karen Yee, Steven Chan, Suzanne Kamel-Reid, Vikas Gupta
Publicat a HemaSphere (2018-06-01)

Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute...

per Tracy Murphy, Jinfeng Zou, Andrea Arruda, Ting Ting Wang, Zhen Zhao, Yangqiao Zheng, Vikas Gupta, Dawn Maze, Caroline McNamara, Mark D. Minden, Aaron Schimmer, Hassan Sibai, Karen Yee, Jose-Mario Capo-Chichi, Tracy Stockley, Andre Schuh, Scott V. Bratman, Steven M. Chan
Publicat a Haematologica (2023-06-01)

Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapy

per Jay Y. Spiegel, Caroline McNamara, James A. Kennedy, Tony Panzarella, Andrea Arruda, Tracy Stockley, Mahadeo Sukhai, Mariam Thomas, Justyna Bartoszko, Jenny Ho, Nancy Siddiq, Dawn Maze, Aaron Schimmer, Andre Schuh, Hassan Sibai, Karen Yee, Jamie Claudio, Rebecca Devlin, Mark D. Minden, Suzanne Kamel-Reid, Vikas Gupta
Publicat a Blood Advances (2017-09-01)